Jia Yi Fong

Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses

P. Lum, B. Louie, Xiaoying Koh, 2022, bioRxiv.

PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis

Dachuan Huang, C. Ong, A. Jeyasekharan, 2020, Nature Communications.

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir

Boping Liu, Xiaoying Koh, J. Joy, 2022, ACS medicinal chemistry letters.

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

Bas J. Wouters, M. Minden, O. Abdel-Wahab, 2019, Cancer cell.

A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors

J. Joy, Gang Wang, R. Karuna, 2021, Bioorganic & Medicinal Chemistry Letters.